Log In
BCIQ
Print this Print this
 

AL-335

  Manage Alerts
Collapse Summary General Information
Company Johnson & Johnson
DescriptionUridine-based nucleotide analog inhibitor of HCV NS5B polymerase
Molecular Target HCV NS5B polymerase
Mechanism of ActionHCV non-structural protein 5B inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationHepatitis C virus (HCV)
Indication DetailsTreat chronic HCV genotype 1 infection; Treat HCV infection
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today